Bylicki O, Tomasini P, Radj G, Guisier F, et al. Atezolizumab with or without bevacizumab and platinum-pemetrexed in patients with stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies: A multicentre phase II o Eur J Cancer 2023;183:38-48.
PMID: 36801605